Clay B. Siegall - Jul 29, 2025 Form 4 Insider Report for Immunome Inc. (IMNM)

Role: President and CEO, Director
Signature: /s/ Sandra Stoneman, Attorney-in-Fact
Stock symbol: IMNM
Transactions as of: Jul 29, 2025
Transactions value $: $0
Form type: 4
Date filed: 7/31/2025, 06:51 PM
Previous filing: Jul 16, 2025
Next filing: Aug 27, 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
SIEGALL CLAY B	President and CEO, Director	C/O IMMUNOME, INC., 18702 N. CREEK PARKWAY, SUITE 100, BOTHELL	/s/ Sandra Stoneman, Attorney-in-Fact	2025-07-31	0001167496

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	IMNM	Employee Stock Option (right to buy)	Award	$0	+800K		$0.00	800K	Jul 29, 2025	Common Stock	800K	$10.60	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	25% of the shares subject to the options vest on July 29, 2026, and one-thirty-sixth (1/36th) of the remaining shares subject to the options shall vest every month thereafter.